The Novel Coronavirus (SARS-CoV-2) and Influenza A/B Virus Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is a real-time RT-PCR test intended for the qualitative detection of
nucleic acids from the SARS-CoV-2, Influenza A and Influenza B in nasopharyngeal/oropharyngeal swab, sputum and bronchoalveolar lavage from individuals meeting WHO SARS-CoV-2
clinical criteria (e.g., clinical signs and symptoms associated with SARS-CoV-2 infection) in conjunction with WHO SARS-CoV-2 epidemiological criteria (e.g., history of residence in or travel to
a geographic region with active SARS-CoV-2 transmission at the time of travel, or other epidemiologic criteria for which SARS-CoV-2 testing may be indicated), suspected cases of influenza A
virus and influenza B virus infection and other persons requiring the diagnosis or differential diagnosis of febrile respiratory infection.